Download PDF
Endoscopy 2007; 39(4): 319-324
DOI: 10.1055/s-2007-966263
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Covered self-expandable metal stents in pancreatic malignancy regardless of resectability: a new concept validated by a decision analysis

M.  Kahaleh1 , A.  Brock1 , M.  R.  Conaway2 , V.  M.  Shami1 , J.  M.  Dumonceau3 , P.  G.  Northup1 , J.  Tokar1 , T.  A.  Rich4 , R.  B.  Adams5 , P.  Yeaton1
  • 1Digestive Health Center, University of Virginia Health System, Charlottesville, Virginia, USA
  • 2Department of Biostatistics, University of Virginia Health System, Charlottesville, Virginia, USA
  • 3Department of Gastroenterology, University Hospital of Geneva, Geneva, Switzerland
  • 4Department of Radiation Oncology, University of Virginia Health System, Charlottesville, Virginia, USA
  • 5Department of Surgery, University of Virginia Health System, Charlottesville, Virginia, USA
Further Information

Publication History

submitted 22 February 2006

accepted after revision 21 November 2006

Publication Date:
15 March 2007 (online)

Also available at
    Permissions and Reprints

See also:

Commentaire de travail de M. Kahaleh et al., pp. 319Endoscopy 2007; 39(04): 382-383
DOI: 10.1055/s-0032-1306923

Background and study aims: The current treatment model for the management of malignant biliary obstruction is to place a plastic stent for unstaged pancreatic cancer. In patients with unresectable disease but a life expectancy of more than 6 months, self-expandable metal stents (SEMS) are favored because of their more prolonged patency. We analyzed the efficacy and cost-effectiveness of covered SEMS (CSEMS) in patients with pancreatic cancer and distal biliary obstruction without regard to surgical resectability.

Patients and methods: Between March 2001 and March 2005, 101 consecutive patients with obstructive jaundice secondary to pancreatic cancer underwent placement of a CSEMS. Patients with resectable tumor were offered pancreaticoduodenectomy. A model was developed to compare the costs of CSEMS and polyethylene and DoubleLayer stents.

Results: A total of 21 patients underwent staging laparoscopy, of whom 16 had a resection (76 %). The 85 patients who did not have a resection had a mean survival of 5.9 months (range 1 - 25 months) and a mean CSEMS patency duration of 5.5 months (range 1 - 16 months). Life-table analysis demonstrated CSEMS patency rates of 97 % at 3 months, 85 % at 6 months, and 68 % at 12 months. In a cost model that accounted for polyethylene and DoubleLayer stent malfunction and surgical resections, initial CSEMS placement (€ 3177 per patient) was a less costly intervention than either DoubleLayer stent placement (€ 3224 per patient) or polyethylene stent placement with revision (€ 3570 per patient).

Conclusions: Covered SEMS are an effective treatment for distal biliary obstructions caused by pancreatic carcinoma. Their prolonged patency and removability makes them an attractive option for biliary decompression, regardless of resectability. The strategy of initial covered SEMS placement might be the most cost-effective strategy in these patients.

References

  • 1 Warshaw A L, Fernandez-del Castillo C. Pancreatic carcinoma.  N Engl J Med. 1992;  326 455-465
    PubMedGoogle Scholar
  • 2 Shepherd H A, Royle G, Ross A P. et al . Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial.  Br J Surg. 1988;  75 1166-1168
    CrossrefPubMedGoogle Scholar
  • 3 Smith A C, Dowsett J F, Russell R C. et al . Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction.  Lancet. 1994;  344 1655-1660
    CrossrefPubMedGoogle Scholar
  • 4 Andersen J R, Sorensen S M, Kruse A. et al . Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice.  Gut. 1989;  30 1132-1135
    CrossrefPubMedGoogle Scholar
  • 5 Prat F, Chapat O, Ducot B. et al . A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct.  Gastrointest Endosc. 1998;  47 1-7
    CrossrefPubMedGoogle Scholar
  • 6 Arguedas M R, Heudebert G H, Stinnett A A, Wilcox C M. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis.  Am J Gastroenterol. 2002;  97 898-904
    CrossrefPubMedGoogle Scholar
  • 7 Isayama H, Komatsu Y, Tsujino T. et al . A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction.  Gut. 2004;  53 729-734
    CrossrefPubMedGoogle Scholar
  • 8 Kahaleh M, Tokar J, Le T, Yeaton P. Removal of self-expandable metallic Wallstents.  Gastrointest Endosc. 2004;  60 640-644
    CrossrefPubMedGoogle Scholar
  • 9 Familiari P, Bulajic M, Mutignani M. et al . Endoscopic removal of malfunctioning biliary self-expandable metallic stents.  Gastrointest Endosc. 2005;  62 903-910
    CrossrefPubMedGoogle Scholar
  • 10 Tringali A, Mutignani M, Perri V. et al . A prospective, randomized multicenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures.  Endoscopy. 2003;  35 992-997
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Kahaleh M, Tokar J, Conaway M R. et al . Efficacy and complications of covered Wallstents in malignant distal biliary obstruction.  Gastrointest Endosc. 2005;  61 528-533
    CrossrefPubMedGoogle Scholar
  • 12 Greenlee R T, Hill-Harmon M B, Murray T, Thun M. Cancer statistics, 2001.  CA Cancer J Clin. 2001;  51 15-36
    CrossrefPubMedGoogle Scholar
  • 13 Barkin J S, Goldstein J A. Diagnostic approach to pancreatic cancer.  Gastroenterol Clin North Am. 1999;  28 709-722, xi
    CrossrefPubMedGoogle Scholar
  • 14 Luman W, Cull A, Palmer K R. Quality of life in patients stented for malignant biliary obstructions.  Eur J Gastroenterol Hepatol. 1997;  9 481-484
    PubMedGoogle Scholar
  • 15 Ballinger A B, McHugh M, Catnach S M. et al . Symptom relief and quality of life after stenting for malignant bile duct obstruction.  Gut. 1994;  35 467-470
    CrossrefPubMedGoogle Scholar
  • 16 Abraham N S, Barkun J S, Barkun A N. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life.  Gastrointest Endosc. 2002;  56 835-841
    CrossrefPubMedGoogle Scholar
  • 17 Knyrim K, Wagner H J, Pausch J, Vakil N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.  Endoscopy. 1993;  25 207-212
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Kaassis M, Boyer J, Dumas R. et al . Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study.  Gastrointest Endosc. 2003;  57 178-182
    CrossrefPubMedGoogle Scholar
  • 19 Davids P H, Groen A K, Rauws E A. et al . Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.  Lancet. 1992;  340 1488-1492
    CrossrefPubMedGoogle Scholar
  • 20 Levy M J, Baron T H, Gostout C J. et al . Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach.  Clin Gastroenterol Hepatol. 2004;  2 273-285
    CrossrefPubMedGoogle Scholar
  • 21 Yeoh K G, Zimmerman M J, Cunningham J T, Cotton P B. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis.  Gastrointest Endosc. 1999;  49 466-471
    PubMedGoogle Scholar
  • 22 Shim C S, Lee Y H, Cho Y D. et al . Preliminary results of a new covered biliary metal stent for malignant biliary obstruction.  Endoscopy. 1998;  30 345-350
    PubMedGoogle Scholar
  • 23 Thurnher S A, Lammer J, Thurnher M M. et al . Covered self-expanding transhepatic biliary stents: clinical pilot study.  Cardiovasc Intervent Radiol. 1996;  19 10-14
    CrossrefPubMedGoogle Scholar
  • 24 Rossi P, Bezzi M, Salvatori F M. et al . Clinical experience with covered Wallstents for biliary malignancies: 23-month follow-up.  Cardiovasc Intervent Radiol. 1997;  20 441-447
    CrossrefPubMedGoogle Scholar
  • 25 Born P, Neuhaus H, Rösch T. et al . Initial experience with a new, partially covered Wallstent for malignant biliary obstruction.  Endoscopy. 1996;  28 699-702
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Hausegger K A, Thurnher S, Bodendorfer G. et al . Treatment of malignant biliary obstruction with polyurethane-covered Wallstents.  AJR Am J Roentgenol. 1998;  170 403-408
    PubMedGoogle Scholar
  • 27 Isayama H, Komatsu Y, Tsujino T. et al . Polyurethane-covered metal stent for management of distal malignant biliary obstruction.  Gastrointest Endosc. 2002;  55 366-370
    CrossrefPubMedGoogle Scholar
  • 28 Bezzi M, Zolovkins A, Cantisani V. et al . New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction.  J Vasc Interv Radiol. 2002;  13 581-589
    CrossrefPubMedGoogle Scholar
  • 29 Nakai Y, Isayama H, Komatsu Y. et al . Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction.  Gastrointest Endosc. 2005;  62 742-774
    CrossrefPubMedGoogle Scholar
  • 30 Hawes R H. Diagnostic and therapeutic uses of ERCP in pancreatic and biliary tract malignancies.  Gastrointest Endosc. 2002;  56 S201-S205
    CrossrefPubMedGoogle Scholar
  • 31 Wamsteker E J, Elta G H. Migration of covered biliary self-expanding metallic stents in two patients with malignant biliary obstruction.  Gastrointest Endosc. 2003;  58 792-793
    CrossrefPubMedGoogle Scholar
  • 32 Matsushita M, Takakuwa H, Nishio A. et al . Open-biopsy-forceps technique for endoscopic removal of distally migrated and impacted biliary metallic stents.  Gastrointest Endosc. 2003;  58 924-927
    CrossrefPubMedGoogle Scholar
  • 33 Miyayama S, Matsui O, Terayama N. et al . Covered gianturco stents for malignant biliary obstruction: preliminary clinical evaluation.  J Vasc Interv Radiol. 1997;  8 641-648
    PubMedGoogle Scholar
  • 34 Wasan S M, Ross W A, Staerkel G A, Lee J H. Use of expandable metallic biliary stents in resectable pancreatic cancer.  Am J Gastroenterol. 2005;  100 2056-2061
    CrossrefPubMedGoogle Scholar
  • 35 Mullen J T, Lee J H, Gomez H F. et al . Pancreaticoduodenectomy after placement of endobiliary metal stents.  J Gastrointest Surg. 2005;  9 1094-1105
    CrossrefPubMedGoogle Scholar
  • 36 Chen V K, Arguedas M R, Baron T H. Expandable metal biliary stents before pancreaticoduodenectomy for pancreatic cancer: a Monte-Carlo decision analysis.  Clin Gastroenterol Hepatol. 2005;  3 1229-1237
    CrossrefPubMedGoogle Scholar

M. Kahaleh, MD

Digestive Health Center

Box 800 708

University of Virginia Health System

Charlottesville

Virginia 22908-0708

USA

Fax: +1-434-924-0491

Email: mk5ke@virginia.edu

      >